Drawing for EVERSANA

USPTO serial 88054633

EVERSANA

Reviewed by CopyMark Law Group

Reg. 6086282Status 702Renewal
Filing date
Status date
Registration date
Jun 23, 2020
Examiner
WELLS, KELLEY L
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with EVERSANA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,493*

Plus Government fees of $2,975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Francelina M. Perdomo Klukosky

Francelina M. Perdomo Klukosky SAUL EWING LLP1270 Avenue of the Americas, Suite 2800New York, NY 10020United States

Goods and services

ClassDescriptionStatusFirst use
035Business consultation services in the health care and biopharma industry; market research services, for drug companies, biologic companies, medical device companies, or other companies in the healthcare field; clinical trial referral services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; call-center support services, namely, operation of telephone call centers for others; business services provided to the life sciences, biopharmaceutical, and medical technology industries, namely, reporting and collecting biopharmaceutical and medical technology product complaints; business consulting services in the life sciences field; business management services in the healthcare field; import and export agency services; providing advertising, marketing and promotional services for the pharmaceutical and medical industry; operation of telephone call centers for others in the field of pharmaceutical, biotechnology, medical devices and healthcare manufactures; providing an online database featuring information as to the availability of pharmaceutical, biotechnology, medical devices healthcare and life sciences goods and services for purchase; patient relationship management services; advertising, promotion, and marketing services for the pharmaceutical, biotech and medical industries; pharmaceutical services, namely, processing online and telephone prescription orders in specialty pharmacies; pharmaceutical cost management services and drug utilization review services; mail order pharmacy services; business consulting services in the life sciences field; business management services in the life sciences field; providing an on-line computer database featuring trade information in the field of pharmaceutical, biotechnology and healthcare manufacturer product pricing, reimbursement data and assistance, and management of copays; providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals and life sciences; patient assistance program support services, namely, customer service management for others; retail and specialty retail pharmacy servicesACTIVEJan 1, 2019
036Financial services, namely, financial analysis and payer reimbursement, namely, reimbursement payment processing in the field of biopharmaceutical and medical technology products claims; providing a website featuring patient healthcare benefit verification services, patient reimbursement and insurance coverage for pharmaceuticals and medical devices; medical insurance case and utilization review and insurance claims adjustment services for healthcare purchasers and payors; online information services, namely, providing information on insurance formulary coverage changes provided by healthcare companies to external stakeholders such as healthcare providers and patients, and receiving input about insurance plan formulary coverage or policy changes from a user via an online portal and populating pre-existing templates of materials for external audiences; providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; financial administration of patient reimbursement programs; financial administration of pharmacy reimbursement programs and services; pharmaceutical benefit management servicesACTIVEJan 1, 2019
038Communications services, namely, transmission of voice, audio, visual images and data by telecommunications networks, wireless communication networks, the Internet, information services networks and data networks in the field of managed healthcare markets; electronic data interchange services in the field of healthcare transactions such as claims, eligibility, claim status, electronic remittance advice, prior authorizations, attachments and referrals that allow direct transaction and payment communications between healthcare providers and payersACTIVEJan 1, 2019
039Supply chain services, namely, warehousing and transportation and delivery of goods for others by air, rail, ship, truck; pharmacy packaging services that aligns, sorts and packages a patient's medications by date and time into individual packets; reverse logistics packaging services, namely, packing of goods of others for shipment purposesACTIVEJan 1, 2019
042Research and testing services in the field of pharmaceutical, biotechnology, medical devices and healthcare manufactures; medical research; conducting clinical trials for others in the life sciences, biopharmaceutical, and medical technology fields; providing a website featuring technology to allows users to determine a patient's healthcare benefit verification services, a patient's prescription medication co-payment, to process insurance company approvals and to verify prescription medications; computer software consultancy rendered to pharmaceutical companies in the field of drug pricing and medical device pricing; providing a web hosting platform for hosting virtual advisory boards, speaker trainings and peer-to-peer programs for stakeholders in the health care community, namely, medical and pharmaceutical suppliers, healthcare professionals and payer representativesACTIVEJan 1, 2019
044Consulting services in the field of healthcare for pharmaceutical, biotechnology and healthcare manufactures; health care services, namely, managed health care services; pharmaceutical advice; dispensing pharmaceuticals; maintaining patient medical records and files; providing information to patients in the field of administering medications; provision of healthcare information in the field of physician groups services, health systems and hospitals, HMOs and insurance providers, regional market data, drug product and customer response data; patient support services and patient advocacy services, namely, providing health care information by telephone; patient support services, namely, medical consultations provided via phone, online chat or videoconferencing; patient support services and patient advocacy services, namely, consulting services in the field of health; health care services, namely, disease management programsACTIVEJan 1, 2019
045Providing licensing, regulatory, and compliance services, namely, licensing of intellectual property, regulatory compliance consulting in the life sciences, biopharmaceutical, and medical technology fields, reviewing standards and practices to assure compliance with food and drug industry laws and regulations; providing patient advocate services to hospital patients and patients in long term care facilities; Providing patient advocate services to individuals in need of medical and health care services; Providing case management services, namely, coordinating legal, medical, physical, social, personal care and psychological services in the field of health care, acute and chronic disease management, long-term care, cancer treatment, and medical treatment; Providing patient advocate and case management services, namely, coordinating the procurement and administration of medicationACTIVEJan 1, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 16, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 16, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 8, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 18, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Dec 23, 2025ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Sep 5, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 23, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 28, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 28, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 28, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 28, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 28, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 28, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 12, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 23, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 19, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 16, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 23, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 23, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 9, 2020IUAFUSE AMENDMENT FILED—
Apr 9, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 12, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 12, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 12, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 12, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 12, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 17, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 15, 2020EX1GSOU EXTENSION 1 GRANTED—
Jan 15, 2020EXT1SOU EXTENSION 1 FILED—
Jan 15, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 26, 2019ALIEASSIGNED TO LIE—
Apr 15, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 13, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 12, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 12, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 19, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 19, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 19, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2018DOCKASSIGNED TO EXAMINER—
Aug 1, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 30, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance